Stonehage Fleming Financial Services’s Pfizer PFE Stock Holding History

Stonehage Fleming Financial Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.9K	Hold	3,735	–	–	﹤0.01%	161
2026 Q1	$105K	Hold	3,735	–	–	﹤0.01%	172
2025 Q4	$93K	Hold	3,735	–	–	﹤0.01%	173
2025 Q3	$95.2K	Hold	3,735	–	–	﹤0.01%	164
2025 Q2	$90.5K	Hold	3,735	–	–	﹤0.01%	162
2025 Q1	$94.6K	Hold	3,735	–	–	﹤0.01%	139
2024 Q4	$99.1K	Hold	3,735	–	–	﹤0.01%	160
2024 Q3	$108K	Hold	3,735	–	–	﹤0.01%	152
2024 Q2	$105K	Buy	+3,735	New	+$103K	﹤0.01%	154
2024 Q1	–	Sell	-3,220	Closed	-$92.7K	–	239
2023 Q4	$92.7K	Sell	3,220 -4,000	-55%	-$121K	﹤0.01%	154
2023 Q3	$239K	Sell	7,220 -10,312	-59%	-$365K	0.02%	139
2023 Q2	$643K	Buy	+17,532	New	+$682K	0.02%	87
2022 Q3	–	Sell	-16,752	Closed	-$878K	–	244
2022 Q2	$878K	Buy	16,752 +13,532	+420%	+$690K	0.04%	74
2022 Q1	$166K	Sell	3,220 -3,000	-48%	-$156K	0.01%	149
2021 Q4	$367K	Hold	6,220	–	–	0.01%	133
2021 Q3	$268K	Hold	6,220	–	–	0.01%	144
2021 Q2	$244K	Sell	6,220 -500	-7%	-$19.4K	0.01%	135
2021 Q1	$243K	Sell	6,720 -1,000	-13%	-$35.5K	0.01%	138
2020 Q4	$284K	Buy	7,720 +4,326	+127%	+$159K	0.01%	128
2020 Q3	$118K	Hold	3,394	–	–	﹤0.01%	133
2020 Q2	$105K	Hold	3,394	–	–	0.01%	113
2020 Q1	$105K	Hold	3,394	–	–	0.01%	139
2019 Q4	$126K	Hold	3,394	–	–	0.01%	143
2019 Q3	$116K	Sell	3,394 -1,581	-32%	-$57.5K	0.01%	141
2019 Q2	$204K	Buy	4,975 +1,581	+47%	+$62.8K	0.01%	117
2019 Q1	$137K	Sell	3,394 -5,270	-61%	-$211K	0.01%	145
2018 Q4	$359K	Hold	8,664	–	–	0.02%	123
2018 Q3	$362K	Hold	8,664	–	–	0.02%	132
2018 Q2	$298K	Hold	8,664	–	–	0.01%	153
2018 Q1	$292K	Hold	8,664	–	–	0.02%	145
2017 Q4	$298K	Hold	8,664	–	–	0.02%	156
2017 Q3	$293K	Sell	8,664 -3,162	-27%	-$102K	0.01%	162
2017 Q2	$377K	Hold	11,826	–	–	0.02%	149
2017 Q1	$384K	Hold	11,826	–	–	0.02%	181
2016 Q4	$364K	Sell	11,826 -10,668	-47%	-$326K	0.02%	177
2016 Q3	$723K	Buy	22,494 +9,951	+79%	+$333K	0.04%	127
2016 Q2	$419K	Sell	12,543 -5,375	-30%	-$172K	0.03%	150
2016 Q1	$503K	Buy	17,918 +16,126	+900%	+$461K	0.03%	136
2015 Q4	$55K	Hold	1,792	–	–	﹤0.01%	109
2015 Q3	$53K	Buy	+1,792	New	+$57.5K	0.01%	118

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stonehage Fleming Financial Services's PFE Position: Q2 2026 in Review

Stonehage Fleming Financial Services held its Pfizer (PFE) position steady in Q2 2026 at 3,735 shares worth $89.9K. The position accounts for ﹤0.01% of the portfolio, ranked #161.

Stonehage Fleming Financial Services first reported a position in PFE in Q3 2015 and has held it in 40 quarters since. The position peaked at $878K in Q2 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Stonehage Fleming Financial Services held 3,735 shares of Pfizer worth $89.9K as of Q2 2026.
Stonehage Fleming Financial Services left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #161 holding.
Stonehage Fleming Financial Services first reported a position in Pfizer in Q3 2015 and has held it in 40 quarters since.
Stonehage Fleming Financial Services's Pfizer position peaked at $878K in Q2 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.